SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending after a massive preliminary Q4 update showing record-breaking order backlogs and gross margins nearly doubling current guidance. This surprise news has ignited significant community debate, with bulls anticipating a major short squeeze and potential re-rating, while skeptics remain focused on long-standing accounting concerns and volatility.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors aggressively position themselves ahead of the company's upcoming earnings release, which is viewed as a pivotal catalyst for the broader AI infrastructure trade. Market participants are intensely focused on management's CapEx guidance, with a heated debate ongoing about whether continued heavy AI investment will drive long-term dominance or strain margins amid ongoing scrutiny of the company's competitive standing against industry rivals.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is currently trending due to community excitement surrounding its role in the AI-blockchain narrative and recent technical developments, with many investors actively debating whether to accumulate during the current period of market volatility. Discussion boards are heavily focused on its long-term potential as decentralized infrastructure, alongside speculation on how institutional adoption and broader sector rotations will influence its future price action.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and social activity as investors debate the potential for a new growth phase driven by its role in Japan's blockchain ecosystem and evolving IoT data use cases. While some community members are actively accumulating based on long-term project belief, others express deep skepticism regarding the asset's utility and historical price performance, leading to intense friction between bullish long-term holders and bearish traders.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is facing intensified market scrutiny following reports of delays to its Gemini 3.5 Pro model, which have triggered investor concerns regarding the company's AI execution and competitive standing against rivals like OpenAI and Anthropic. The community remains heavily divided as they anticipate upcoming earnings, with many viewing the dip as a strategic accumulation opportunity for a long-term AI leader while others worry that rising capital expenditure requirements could weigh on near-term performance.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under pressure as China adds the company to its export control list, sparking investor uncertainty despite the firm's strategic push for supply chain independence. The community is actively debating the stock's long-term potential as a critical defense asset versus its recent technical volatility and the impact of broader sector-wide selling.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is capturing significant investor attention following the executive order to fast-track psychedelic drug research, though the sudden departure of its interim CEO has fueled volatility and intense community debate over management stability. Despite retail excitement surrounding potential priority vouchers and clinical milestones, active discussions frequently focus on the tension between the company's Breakthrough Therapy designation, its cash runway, and ongoing concerns regarding dilution and leadership changes.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors weigh geopolitical risks in the Middle East against central bank gold accumulation and shifts in global monetary policy. The community is actively debating the metal's role as a hedge against inflation and sovereign debt, with many focusing on decoupling trends from tech stocks and potential decoupling from paper-based price discovery systems.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors monitor its strength in the enterprise AI infrastructure market, with community members debating whether the company can maintain momentum amid sector-wide volatility and shifting hyperscaler capital expenditure expectations. Discussion centers on the stock's role as a key AI server beneficiary and its relative performance compared to rivals like Super Micro Computer.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors react to a significant expansion of the National Security Space Launch contract pool, which saw its ceiling increase substantially, alongside continued community focus on its long-term potential in space infrastructure, defense, and the development of the Neutron vehicle. While some investors remain concerned about share price volatility and recent pullbacks, others are actively discussing the stock as a long-term accumulation opportunity due to the company's growing backlog and strategic position in the space sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today? 

Equity

Investors showed confidence in healthcare improvements, strong biotech patents, and rising packaging demand. 


CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.

Noteworthy Tuesday Option Activity: GM, BA, CVS

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in General Motors Co (Symbol: GM), where a total of 43,084 contracts have traded so far, representing approximately 4.3 million underlying shares. That amounts to about 60.1...

Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 adjusted EPS outlook.

CVS Health To Sell Pet Medications At Its Pharmacies

(RTTNews) - On Tuesday, CVS Health Corp. (CVS) announced avilability of common prescription medications for dogs and cats at its approximately 9000 pharmacy locations across the US...

Pet medications now available at CVS Pharmacy

Pet medications now available at CVS Pharmacy Pet medications now available at CVS Pharmacy PR Newswire WOONSOCKET, R.I., July 21, 2026 Dog and cat owners can now fill common pet prescriptions at all CVS Pharmacy locations nationwideWOONSOCKET, R.I., July 21, 2026 /PRNewswire/ -- CVS Health...

California wealth charts a quieter path to Florida as Gulf Coast enters multibillion-dollar boom

For decades, the standard play for wealthy out-of-state transplants was to head straight for the high-octane flash of Florida's East Coast. But as California's housing affordability challenges, homelessness and proposals for higher taxes have pushed some families to a state of constant "high...

CVS Pharmacy celebrates opening of first pharmacy-focused location in Houston

CVS Pharmacy celebrates opening of first pharmacy-focused location in Houston CVS Pharmacy celebrates opening of first pharmacy-focused location in Houston PR Newswire WOONSOCKET, R.I., July 17, 2026 Pharmacy-focused sites to open in select communities to help increase access to pharmacy...

Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?

Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.

Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market

ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Cancer Diagnostics fuel growth despite Nutrition weakness.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$110.60
Prev Close	$107.61
Open	$107.84
Dividend Yield	3.35%
50-Day Moving Average	$99.20
Beta	0.31
Avg. Volume	8.6M
PE Ratio	48.57

52-Week High	$110.62
52-Week Low	$58.50
Market Capitalization	$137.3B
EPS (Annual)	$1.39
Price to Book	1.82
Revenue Per Employee	$1.34M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CVSCVS Health Corp

Latest CVS News